Bank of New York Mellon
BHVN

Bank of New York Mellon’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bank of New York Mellon’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,000,497
Closed -$151M – 4645
2022
Q3 		$151M Sell
1,000,497
-14,912
-1% -$2.25M 0.04% 442
2022
Q2 		$148M Sell
1,015,409
-139,545
-12% -$20.3M 0.03% 460
2022
Q1 		$137M Sell
1,154,954
-44,441
-4% -$5.27M 0.03% 541
2021
Q4 		$165M Sell
1,199,395
-51,048
-4% -$7.03M 0.03% 487
2021
Q3 		$174M Buy
1,250,443
+18,715
+2% +$2.6M 0.03% 461
2021
Q2 		$120M Buy
1,231,728
+44,535
+4% +$4.32M 0.02% 622
2021
Q1 		$81.1M Buy
1,187,193
+375,612
+46% +$25.7M 0.02% 812
2020
Q4 		$69.6M Buy
811,581
+13,117
+2% +$1.12M 0.02% 835
2020
Q3 		$51.9M Buy
798,464
+5,903
+0.7% +$384K 0.01% 893
2020
Q2 		$57.9M Buy
792,561
+91,467
+13% +$6.69M 0.02% 798
2020
Q1 		$23.9M Buy
701,094
+149,558
+27% +$5.09M 0.01% 1186
2019
Q4 		$30M Sell
551,536
-10,206
-2% -$556K 0.01% 1311
2019
Q3 		$23.4M Buy
561,742
+16,148
+3% +$674K 0.01% 1433
2019
Q2 		$23.9M Buy
545,594
+383,594
+237% +$16.8M 0.01% 1457
2019
Q1 		$8.34M Buy
162,000
+24,538
+18% +$1.26M ﹤0.01% 2065
2018
Q4 		$5.08M Sell
137,462
-2,229
-2% -$82.4K ﹤0.01% 2278
2018
Q3 		$5.25M Sell
139,691
-2,071
-1% -$77.8K ﹤0.01% 2382
2018
Q2 		$5.6M Buy
141,762
+20,364
+17% +$805K ﹤0.01% 2332
2018
Q1 		$3.13M Buy
121,398
+78,477
+183% +$2.02M ﹤0.01% 2579
2017
Q4 		$1.16M Sell
42,921
-19,834
-32% -$535K ﹤0.01% 3148
2017
Q3 		$2.35M Buy
62,755
+10,398
+20% +$389K ﹤0.01% 2752
2017
Q2 		$1.31M Buy
+52,357
New +$1.31M ﹤0.01% 3094